Gumerlock PH - Search Results

1

Current strategies in the management of hormone refractory prostate cancer.

Martel CL, Gumerlock PH, Meyers FJ, Lara PN. Martel CL, et al. Among authors: gumerlock ph. Cancer Treat Rev. 2003 Jun;29(3):171-87. doi: 10.1016/s0305-7372(02)00090-7. Cancer Treat Rev. 2003. PMID: 12787712 Review.

2

HER-2/neu is overexpressed infrequently in patients with prostate carcinoma. Results from the California Cancer Consortium Screening Trial.

Lara PN Jr, Meyers FJ, Gray CR, Edwards RG, Gumerlock PH, Kauderer C, Tichauer G, Twardowski P, Doroshow JH, Gandara DR. Lara PN Jr, et al. Among authors: gumerlock ph. Cancer. 2002 May 15;94(10):2584-9. doi: 10.1002/cncr.10526. Cancer. 2002. PMID: 12173324 Free article. Clinical Trial.

3

Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial.

Lara PN Jr, Chee KG, Longmate J, Ruel C, Meyers FJ, Gray CR, Edwards RG, Gumerlock PH, Twardowski P, Doroshow JH, Gandara DR. Lara PN Jr, et al. Among authors: gumerlock ph. Cancer. 2004 May 15;100(10):2125-31. doi: 10.1002/cncr.20228. Cancer. 2004. PMID: 15139054 Free article. Clinical Trial.

4

Predictive molecular markers: has the time come for routine use in lung cancer?

Davies AM, Mack PC, Lara PN Jr, Lau DH, Danenberg K, Gumerlock PH, Gandara DR. Davies AM, et al. Among authors: gumerlock ph. J Natl Compr Canc Netw. 2004 Mar;2(2):125-31. doi: 10.6004/jnccn.2004.0011. J Natl Compr Canc Netw. 2004. PMID: 19777702 Review.

5

Activated ras alleles in human carcinoma of the prostate are rare.

Gumerlock PH, Poonamallee UR, Meyers FJ, deVere White RW. Gumerlock PH, et al. Cancer Res. 1991 Mar 15;51(6):1632-7. Cancer Res. 1991. PMID: 1998954

6

Molecular biology of prostate carcinogenesis.

Lara PN Jr, Kung HJ, Gumerlock PH, Meyers FJ. Lara PN Jr, et al. Among authors: gumerlock ph. Crit Rev Oncol Hematol. 1999 Dec;32(3):197-208. doi: 10.1016/s1040-8428(99)00041-4. Crit Rev Oncol Hematol. 1999. PMID: 10633849 Review. No abstract available.

7

Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: phase II Southwest Oncology Group Study S9504.

Gandara DR, Chansky K, Albain KS, Leigh BR, Gaspar LE, Lara PN Jr, Burris H, Gumerlock P, Kuebler JP, Bearden JD 3rd, Crowley J, Livingston R; Southwest Oncology Group. Gandara DR, et al. J Clin Oncol. 2003 May 15;21(10):2004-10. doi: 10.1200/JCO.2003.04.197. J Clin Oncol. 2003. PMID: 12743155 Clinical Trial.

8

Integration of novel therapeutics into combined modality therapy of locally advanced non-small cell lung cancer.

Gandara D, Narayan S, Lara PN Jr, Goldberg Z, Davies A, Lau DH, Mack P, Gumerlock P, Vijayakumar S. Gandara D, et al. Clin Cancer Res. 2005 Jul 1;11(13 Pt 2):5057s-5062s. doi: 10.1158/1078-0432.CCR-05-9012. Clin Cancer Res. 2005. PMID: 16000614 Review.

9

Tirapazamine: prototype for a novel class of therapeutic agents targeting tumor hypoxia.

Gandara DR, Lara PN Jr, Goldberg Z, Le QT, Mack PC, Lau DH, Gumerlock PH. Gandara DR, et al. Among authors: gumerlock ph. Semin Oncol. 2002 Feb;29(1 Suppl 4):102-9. doi: 10.1053/sonc.2002.31531. Semin Oncol. 2002. PMID: 11894020 Review.

10

Cell cycle-dependent potentiation of cisplatin by UCN-01 in non-small-cell lung carcinoma.

Mack PC, Gandara DR, Lau AH, Lara PN Jr, Edelman MJ, Gumerlock PH. Mack PC, et al. Among authors: gumerlock ph. Cancer Chemother Pharmacol. 2003 Apr;51(4):337-48. doi: 10.1007/s00280-003-0571-6. Epub 2003 Mar 25. Cancer Chemother Pharmacol. 2003. PMID: 12721762

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters